A MACHINE LEARNING PIPELINE FOR DISCRIMINANT
PATHWAYS IDENTIFICATION
Annalisa Barla(1) , Giuseppe Jurman(2) , Roberto Visintainer(2,3) Margherita
Squillario(1) , Michele Filosi(2,4) , Samantha Riccadonna(2) and Cesare
Furlanello(2)

arXiv:1105.4486v2 [q-bio.MN] 27 May 2011

1

DISI, University of Genoa, via Dodecaneso 35, I-16146 Genova, Italy.
FBK, via Sommarive 18, I-38123 Povo (Trento), Italy.
3
DISI, University of Trento, via Sommarive 14, I-38123 Povo (Trento), Italy.
4
CIBIO, University of Trento, via Delle Regole 101, I-38123 Mattarello (Trento), Italy
2

CONTENTS
1
2
3

Introduction
System and Methods
Data Description
3.1
Children susceptibility to air pollution
3.2
Clinical stages of Parkinson‚Äôs disease
3.3
Clinical stages of Alzheimer‚Äôs disease
Discussion
4.1
Air Pollution Experiment
4.2
Parkinson‚Äôs Disease Experiment
4.3
Alzheimer‚Äôs Disease Experiment
Conclusion
Appendix
6.1
Experimental setup for the examples
6.1.1 Spectral Regression Discriminant Analysis (SRDA).
6.1.2 The `1 `2 feature selection framework (`1 `2F S ).
6.1.3 Functional Characterization.
6.1.4 Weighted Gene Co-Expression Networks (WGCN).
6.1.5 Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE).
6.1.6 Ipsen-Mikhailov distance .
6.2
Experiments
6.2.1 Air Pollution Experiment
6.2.2 Parkinson‚Äôs Disease Experiment
6.2.3 Alzheimer‚Äôs Disease Experiment

4

5
6

1
2
3
3
3
3
3
3
4
7
9
10
10
10
10
10
10
10
10
11
11
13
17

ABSTRACT
Motivation: Identifying the molecular pathways more prone to disruption during a pathological process is a key task in network medicine and,
more in general, in systems biology.
Results: In this work we propose a pipeline that couples a machine learning solution for molecular profiling with a recent network comparison
method. The pipeline can identify changes occurring between specific sub-modules of networks built in a case-control biomarker study,
discriminating key groups of genes whose interactions are modified by an underlying condition. The proposal is independent from the
classification algorithm used. Three applications on genomewide data are presented regarding children susceptibility to air pollution and two
neurodegenerative diseases: Parkinson‚Äôs and Alzheimer‚Äôs.
Availability: Details about the software used for the experiments discussed in this paper are provided in the Appendix.
Contact: furlan@fbk.eu

1

INTRODUCTION

Nowadays, it is widely accepted as a consolidated fact that most of the known diseases are of systemic nature: their phenotypes can be
attributed to the breakdown of a rather complex set of molecular interaction among the cell‚Äôs components rather than imputed to the
misfunctioning of a single entity such as a gene. A major aim of systems biology and, in particular, of its newly emerging discipline

c 2011


1

Barla et al

known as network medicine (Barabasi et al. (2011)), is the understanding of the cellular wiring diagram at all possible levels of organization
(from transcriptomics to signalling) of the functional design, the molecular pathways being a typical example. Such reconstruction is made
feasible by the recent advances in the theory of complex networks (e.g. Strogatz (2001); Newman (2003); Boccaletti et al. (2006); Newman
(2010); Buchanan et al. (2010)) and, in particular, in the reconstruction algorithms for inferring networks topology and wiring starting from
a collection of high-throughput measurements (He et al. (2009)). However, the tackled problem is hard (‚Äùa daunting task‚Äù, Baralla et al.
(2009)) and these methods are not flawless Marbach et al. (2010), due to many factors. Among them, underdeterminacy is a major issue
(De Smet and Marchal (2010)), and the ratio between the network dimension (number of nodes) and the number of available measurements
to infer interactions plays a key role for the stability of the reconstructed structure. Although some effort has recently been put into facing
this issue, the stability (and thus the reproducibility) of the process is still an open problem.
In this contribution we propose a pipeline for machine learning driven determination of the disruption of important molecular
pathways induced or inducing a condition starting from microarray measurements in a case/control experimental design. The problem of
underdeterminacy in the inference procedure is avoided by focussing only on subnetworks, and the relevance of the studied pathways for the
disease is judged in terms of discriminative relevance for the underlying classification problem. The profiling part of the pipeline, composed of
a classifier and a feature selection method embedded within an adequate experimental procedure or Data Analysis Protocol (The MicroArray
Quality Control Consortium (2010)), is used to rank the genes with the highest discriminative power. These genes undergo an enrichment
phase (Zhang et al. (2005a); Subramanian et al. (2005)) to individuate the involved whole pathways to keep track of the established functional
dependencies that would otherwise get lost by limiting the subnetwork analysis to the sole selected genes. Finally, a network is inferred for
both the case and the control samples on the selected pathways, and the two structure are compared to pinpoint the occurring differences and
thus to detect the relevant pathway related variations.
A noteworthy point of this workflow is the independence from its ingredients: the classifier, the feature ranking algorithm, the enrichment
procedure, the inference method and the network comparison function. This last point is worth a comment: although already fruitfully used
even in a biological context (Sharan and Ideker (2006)), the problem of quantitatively comparing network (e.g. using a metric instead of
evaluating network properties) is a widely open issue affecting many scientific disciplines. As discussed in (Jurman et al. (2011)), many
classical distances (such as those of the edit family) have a relevant drawback in being local, that is focussing only on the portions of the
network interested by the differences in the presence/absence of matching links. More recently, other metrics can overcome this problem so
to consider the global structure of the compared topologies; among such distances, the spectral ones - based on the list of eigenvalues of the
laplacian matrix of the underlying graph - are quite interesting, and, in particular, the Ipsen-Mikhailov (Ipsen and Mikhailov (2002)) distance
has been proven to be the most robust in a wide range of situations.
In what follows we will describe the newly introduced workflow in details, providing three examples of application in problems of
biological interest: the first tasks concerns the transcriptomics consequences of exposition to environmental pollution on a cohort of children
in Czech Republic, the second one investigates the molecular characteristics between Parkinson‚Äôs disease (PD) at early and late stages and
the third regards the characterization of Alzheimer‚Äôs disease (AD) at early and late stages. To strenghten the support to our proposal, the
two problems will be dealt with by using different experimental conditions, i.e., varying the employed algorithms throughout the various
steps of the workflow. In both cases, biologically meaningful considerations can be drawn, consistent with previous findings, showing the
effectiveness of the proposed procedure in the assessment of the occuring subnetwork variations.

2

SYSTEM AND METHODS

The proposed machine learning pipeline handles case/control transcription data through four main steps, from a profiling task output (a
ranked list of genes) to the identification of discriminant pathways, see Figure 1. Alternative algorithms can be used at each step of the
pipeline: as an example in the profiling part different classifiers, regression or feature selection methods can be adopted. In Section 6.1 we
describe the elementary steps used in the experiments.

Gene Expression Data
Feature
selection step

Pathway
Enrichment

Subnetwork
Inference

Subnetwork
Analysis

Phenotype
Classification
Regression

Aracne, WGCNA
SRDA, L1L2

Subnetwork
Comparison

GSEA, GSA
Density

Fig. 1. Schema of the analysis pipeline.

2

Machine Learning Pipeline for Discriminant Pathways Identification

Formally, we are given a collection of n subjects, each described by a p-dimensional vector x of measurements. Each sample is also
associated with a phenotypical label y = {1, ‚àí1}, assigning it to a class (e.g. pollution vs. no-pollution in Section 4.1). The dataset is
therefore represented by an n √ó p gene expression data matrix X, where p >> n and a corresponding labels vector Y .
The matrix X is used to feed the profiling part of the pipeline. We choose a proper Data Analysis Protocol (The MicroArray Quality
Control Consortium (2010)) for ensuring accurate and reproducible results and a prediction model. The model is built as a classifier (e.g.,
SRDA, Cai et al. (2008)) or a regression method (e.g., `1 `2 , De Mol et al. (2009)) coupled with a feature selection algorithm. Thus, we obtain
a ranked list of genes from which we extract a gene signature g1 , ..., gk taking the top-k most discriminant genes. The choice is performed
by finding a balance between the accuracy of the classifier and the stability of the signature (The MicroArray Quality Control Consortium
(2010)).
Applying pathway enrichment techniques (e.g., GSEA or GSA, Zhang et al. (2005a); Subramanian et al. (2005)), we retrieve for each gene
gi the corresponding whole pathway pi = {h1 , ..., ht }, where the genes hj 6= gi not necessarily belong to the original signature g1 , ..., gk .
Extending the analysis to all the hj genes of the pathway allows us to explore functional interactions that would otherwise get lost.
The subnetwork inference phase (e.g., WGCN or ARACNE, Zhao et al. (2010); Meyer et al. (2008)) requires to reconstruct a network
for each pathway pi by using the steady state expression data of the samples of each class y. The network inference procedure is limited to
the sole genes belonging to the pathway pi in order to avoid the problem of intrinsic underdeterminacy of the task. As an additional caution
against this problem, in the following experiments we limit the analysis to pathways having more than 4 nodes and less than 1000 nodes. For
each pi and for each y, we obtain a real-valued adjacency matrix, which is then binarized by choosing a threshold on the correlation values.
This choice requires the construction of a binary adjacency matrix Npi ,y,ts for each pi , for each y and for a grid of threshold values t1 , ..., tT .
For each value ts of the grid, we compute for each pi both the distance D (e.g., the Ipsen-Mikhailov distance, see for details Section 6.1.6)
between the case and control pathway graphs and the corresponding densities. We chose ts providing the best balance between the average
distance across the pathways pi and the network density. For a fixed ts and for each pi , we obtain a score D(Npi ,1,ts , Npi ,‚àí1,ts ) used to
rank the pathways pi . As an additional scoring indicator for g1 , ..., gk , we also provide the difference between the weighted degree in the
control (y = ‚àí1) and in the patient (y = 1) network: ‚àÜd(gi ) = d‚àí1 (gi ) ‚àí d1 (gi ). A final step of biological relevance assessment of the
ranked pathways concludes the pipeline.

3

DATA DESCRIPTION

Section 4 describes three different experiments. In the first experiment we used a genome-wide dataset created for investigating the effects
of air pollution on children. In the second and third experiment we analyzed gene expression data on two neurodegenerative diseases:
Parkinson‚Äôs (PD) and Alzheimer‚Äôs (AD). All the examples are based on publicly available datasets on the Gene Expression Omnibus (GEO).

3.1

Children susceptibility to air pollution

The first dataset (GSE7543) collects data of children living in two regions of the Czech Republic with different air pollution levels (van
Leeuwen et al. (2008, 2006)): 23 children recruited in the polluted area of Teplice and 24 children living in the cleaner area of Prachatice.
Blood samples were hybridized on Agilent Human 1A 22k oligonucleotide microarrays. After normalization we retained 17564 features.

3.2

Clinical stages of Parkinson‚Äôs disease

For PD we consider two publicly available datasets from GEO: GSE6613 (Scherzer et al. (2007)) and GSE20295 (Zhang et al. (2005c)). The
former includes 22 controls and 50 whole blood samples from patients predominantly at early PD stages while the latter is composed of 53
controls and 40 patients with late stage PD. Biological data were hybridized on Affymetrix HG-U133A platform, estimating the expression
of 22215 probesets for each sample.

3.3

Clinical stages of Alzheimer‚Äôs disease

For AD we analyzed two GEO datasets: GSE9770 and GSE5281 (Liang et al. (2010, 2008)). The first includes 74 controls and 34 samples
from non-demented patients with AD (since it is the earliest AD diagnosed, we will label it as early hereafter) and the second is composed
of 74 controls and 80 samples from patients with late onset AD. The samples were extracted from six brain regions, differently susceptible
to the disease: entorhinal cortex (EC), hippocampus (HIP), middle temporal gyrus (MTG), posterior cingulate cortex (PC), superior frontal
gyrus (SFG) and primary visual cortex (VCX). The latter is known to be relatively spared by the disease, therefore we did not consider the
samples within the VCX region. Overall, we analyzed 62 controls and 29 AD samples for GSE9770 and 62 controls and 68 AD samples for
GSE5281. Biological data were hybridized on Affymetrix HG-U133Plus2.0 platform, estimating the expression of 54713 probesets for each
sample.

4
4.1

DISCUSSION
Air Pollution Experiment

The SRDA analysis of the air pollution dataset was performed within a 100√ó5-fold cross validation (CV) schema, producing a gene signature,
characterizing the molecular differences between children in Teplice (polluted) and Prachatice (not polluted). The signature consists of 50
probesets, corresponding to 43 genes, achieving 76% accuracy.

3

Barla et al

The enrichment analysis on the signature allowed a functional characterization of the relevant genes, identifying 11 enriched ontologies in
GO (listed in Appendix Table 4). We then constructed the corresponding WGCN network for the 11 selected pathways for both cases and
controls. Full details about the experiment are reported in Appendix Section 6.2.1.
Table 1. Air Pollution Experiment: most important pathways ranked by the normalized Ipsen-Mikhailov distance ÀÜ. The Entrez gene symbol ID is also
provided for the selected probesets g1 , ..., gk in the corresponding pathway.

Pathway Code

ÀÜ

Gene Symbol

GO:0043066
GO:0001501
GO:0007399
GO:0016787
GO:0005516
GO:0007275
GO:0006954

0.257
0.149
0.093
0.078
0.076
0.076
0.048

MATN3
NRGN
DHX32, CLC
MYH1
FKHL18, HOXB8, OLIG1
PROK2

In Table 1 we report the most biologically relevant pathways, ranked for decreasing normalized Ipsen-Mikhailov distance ÀÜ, which provides
a measure of the structural distance between the networks inferred for the two classes. The most disrupted pathway is GO:0043066, i.e.
apoptosis followed by GO:0001501 i.e. skeletal development. Since the children under study are undergoing natural development, especially
physical changes of their skeleton, the high differentiation between cases and controls of the GO:0001501 and the involvement of pathway
GO:0007275 i.e. developmental process is biologically very sound. Another relevant pathway is GO:0006954, representing the response to
infection or injury caused by chemical or physical agents. Several genes included in GO:0005516, (i.e. calmodulin binding) bind or interact
with calmodulin, that is a calcium-binding protein involved in many essential processes, such as inflammation, apoptosis, nerve growth, and
immune response. This is a key pathway that is linked with all the above mentioned terms as well as to GO:0007399, i.e. nervous system
development, being one of the most stimulated pathways together with GO:0001501.
As described in Section 2 the pipeline also provides a score ‚àÜd of the variation of the number of interactions for g1 , ..., gk . The full list is
provided in Appendix Table 5, here we discuss a subset of the most biologically relevant genes.
FKHL18, HOXB8, PROK2, DHX32, MATN3 are directly involved in the development. CLC is a key element in the inflammation and
immune system. OLIG1 is a transcription factor that works in the oligodendrocytes within the brain. NRGN binds calcium and is a target
for thyroid hormones in the brain. Finally, MYH1 encodes for myosin that is a major contractile protein that forms striated, smooth and
non-muscle cells. MYH1 isoforms show expression that is spatially and temporally regulated during development.
Figure 2 shows the network of the GO:0007399 pathway, related to the nervous system development in the two cohorts. It is clear that
several connections among the genes within this pathway are missing in the subjects living in the polluted area (Teplice). Therefore the
nervous system development in these children is potentially at risk compared to those living in the not polluted city (Prachatice).

(a) Prachatice

(b) Teplice

Fig. 2. Networks of the pathway GO:0007399 (nervous system development) for Prachatice children (a) compared with Teplice children (b). Node diameter
is proportional to the degree, and edge width is proportional to connection strength (estimated correlation).

4.2

Parkinson‚Äôs Disease Experiment

The `1 `2 analysis of the two PD datasets was performed respectively within a 9-fold nested CV loop for the early PD and 8-fold nested
CV for the late PD. The early PD signature consists of 77 probesets, mapped on 70 genes, and associated to 62% accuracy. The late stage
signature is composed of 94 probesets corresponding to 90 genes and achieving 80% accuracy.

4

Machine Learning Pipeline for Discriminant Pathways Identification

Table 2. PD: most important pathways ranked by normalized Ipsen-Mikhailov distance ÀÜ. The Entrez gene symbol ID is also provided for the selected
probesets g1 , ..., gk in the corresponding pathway. In bold, common elements between early and late stage PD.

PD early

PD late

Pathway Code

ÀÜ

GO:0005506
GO:0006952
GO:0045087
GO:0042802
GO:0042802
GO:0006955
GO:0006950
GO:0020037
GO:0005938
GO:0005856
GO:0005856
GO:0003779
GO:0030097
GO:0009615
GO:0009615
GO:0051707

0.38
0.37
0.36
0.33
0.33
0.31
0.28
0.26
0.26
0.24
0.24
0.23
0.15
0.14
0.14
0.00

GO:0019226
GO:0007611
GO:0042493
GO:0009725
GO:0030424
GO:0007267
GO:0005516
GO:0005096
GO:0007610
GO:0003779
GO:0005624
GO:0045202
GO:0003924
GO:0006928
GO:0042995
GO:0007268
GO:0043234
GO:0005525
GO:0006412
GO:0006836
GO:0043005
GO:0043025
GO:0042221
GO:0009266
GO:0014070

0.31
0.16
0.15
0.11
0.10
0.09
0.09
0.09
0.08
0.08
0.08
0.08
0.07
0.07
0.07
0.06
0.06
0.05
0.05
0.05
0.05
0.04
0.00
0.00
0.00

Gene Symbol
HBB
DEFA1/DEFA3
SYT1
HSPB1
DEFA1/DEFA3
HSPB1
HBB
MYH10
VCL
HSPB1
MYH10, VCL

DEFA1/DEFA3

MYH10
TAC1
MYH10, SYT1, RGS4
RGS4
MYH10, VCL
SLC18A2
SYT1
CDC42
HSBP1, VCL
CDC42
TAC1, SYT1
VCL
CDC42
RPS4Y
SLC18A2, SLC6A3
MYH10, SYT1
MYH10

Applying ARACNE, we constructed the relevance network for both cases and controls for the 35 enriched pathways for late stage PD
case and 42 pathways for early stage PD. Table 2 reports the most biologically relevant pathways, ranked for decreasing normalized IpsenMikhailov distance ÀÜ. The full list of the analyzed pathways is provided as Appendix Table 6.
Having characterized the functional alteration of pathways for both early and late stage PD, we attempt a comparative analysis of the
outcome, commenting the most meaningful results from the biological viewpoint. We expected some common pathways between the
two stages, especially within pathways that represent general processes and functions, but as commented in Section 2 the pipeline does
not consider pathways having more that 1000 nodes, hence discarding the general terms in the GO. Indeed, the only common pathway
is GO:0003779, i.e. actin binding. Actin participates in many important cellular processes, including muscle contraction, cell motility,

5

Barla et al

cell division and cytokinesis, vescicle and organelle movement, cell signaling. Clearly, this term is strictly associated to the most evident
movement-related symptoms in PD, including shaking, rigidity, slowness of movement and difficulty with walking and gait.
In both early and late PD we note some alteration within the biological process class of response to stimulus. In the early PD list we
identified GO:0006950 i.e. response to stress, GO:0009615 i.e. response to virus and GO:0051707 i.e. response to other organism. In the late
PD list we found GO:0042493, i.e. response to drug, GO:0009725 i.e. response to hormone stimulus, GO:0042221 i.e. response to chemical
stimulus, GO:0014070 i.e. response to organic cyclic substance and GO:0009266 response to temperature stimulus.
The pathways specific to early PD show a great involvement of the immune system, which is greatly stimulated by inflammation especially
located in particular brain regions (mainly substantia nigra). Indeed, we identified: GO:0006952 i.e. defense response, GO:0045087 i.e.
innate immuno response also visualized in Figure 3, GO:0006955 i.e. immune response and GO:0030097 i.e. hemopoiesis.

(a) early PD patients

(b) controls

Fig. 3. Networks of the pathway GO:0045087 (innate immune response) for PD early development patients (a) compared with healty subjects (b). Node
diameter is proportional to the degree, and edge width is proportional to connection strength (estimated correlation).

From Figure 3 it is clear that since the early stages of PD the innate immune system is severly compromised: the body is highly subjected
to the invasion and proliferation of microbes (like bacteria or viruses), resulting in a debilitated organism, less effective in fighting the
consequent inflammation.
In late stage PD, we detected several differentiated terms related to the Central Nervous System. Among others, we mention: GO:0019226
i.e. transmission of nerve impulse, GO:0007611 i.e. learning or memory, GO:0007610 i.e. behavior and GO:007268 i.e. synaptic
transmission. These findings are fitting the late stage PD scenario, where cognitive and behavioral problems may arise with dementia.
Table 2, and Appendix Table 7 and 8 report the genes belonging to the most relevant pathways for early and late PD, respectively.
Four common genes were identified between early and late stage PD: MYH10, SYT1, VCL and HSPB1. MYH10 is involved in several
pathways: acting binding and calmodulin binding, neural cell body, neuron projection and cell cortex. These pathways indicate that the
damage mostly occurs in the neurons and especially the actin binding and the cell cortex affect the cytoskeleton and the muscular tissue.
At the same time, the calmodulin binding pathway indicates that other preprocesses, related to calmodulin and relevant for PD, might be
damaged. These processes are related to the inflammation, metabolism, apoptosis, smooth muscle contraction, intracellular movement, shortterm, long-term memory, nerve growth and the immune response. Moreover, it is known that MYH10 is involved in the regulation of the
actin cytoskeleton pathways but also in that ones related to the axon guidance. Mutations in this gene are known to be present in disease
phenotypes affecting the heart and the brain (Kim et al. (2005)). The synaptotagmin SYT1, also involved in the calmoduling binding, is
an integral membrane protein of synaptic vesicles thought to serve as Ca(2+) sensor in the process of vesicular trafficking and exocytosis.
Calcium binding to SYT1 participates in triggering neurotransmitter release at the synapse. This protein is therefore involved in the synaptic
transmission and it predominantly works in the neuron projections and synapses. Vinculin (VCL) is a cytoskeletal protein associated with
cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the
membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. This protein is involved in cell motility, proliferation and
differentiation but also in smooth muscle contraction, inflammation and immune surveillance. VCL is located on a locus of chromosome
10 strongly associated with late onset AD (Grupe et al. (2006)). HSPB1 is a heat shock protein induced by environmental stress and
developmental changes. The encoded protein is involved in stress resistance and actin organization and translocates from the cytoplasm to
the nucleus upon stress induction. This translocation occurs in order to modulate SP1-dependent transcriptional activity to promote neuronal
protection (Friedman et al. (2009)). Furthermore, defects in this gene cause two neurophatic diseases (i.e. Charcot-Marie-Tooth disease type
2F and distal hereditary motor neuropathy).
Beside the common genes, early stage PD is characterized by several meaningful genes. HBB encodes for hemoglobin beta that, together
with another hemoglobin beta and two hemoglobin alpha, forms the adult hemoglobin. The work of Atamna and Boyle (2006) shows that the
binding of Abeta to the heme group (hemoglobins bond to iron) supports a unifying mechanism by which excessive Amyloid-beta (Abeta)
induces heme deficiency, causes oxidative damage to macromolecules, and depletes specific neurotransmitters. Althought Abeta is a known
marker for AD, a recent publication also places it within a panel of PD biomarkers (Shi et al. (2011)). DEFA1 and DEFA3 are both defensins,
a family of microbicidal and cytotoxic peptides thought to be involved in host defense. They are abundant in the granules of neutrophils and
also found in the epithelia of mucosal surfaces such as those of the intestine, respiratory tract, urinary tract, and vagina. Recently, Andrianov
et al. (2007) presented some evidence for the recruitment of defensins in communication between the immune and nervous systems in the
frog.

6

Machine Learning Pipeline for Discriminant Pathways Identification

Among the genes specific to the late PD, we note CDC42, a GTPase of the Rho-subfamily, which regulates signaling pathways controlling
diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. Through the interaction with other
proteins, CDC42 is known to regulate actin polymerization constituent both of the cytoskeleton and of the muscle cells. SLC6A3 is a
dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. This gene is associated
with Parkinsonism-dystonia infantile (Kurian et al. (2009)). Other significant genes within Table 2 are: TAC1, RGS4, SLC18A2 and RPS4Y.

4.3

Alzheimer‚Äôs Disease Experiment

Classification and feature selection via `1 `2 , performed within a 9-fold nested CV schema for AD early and 8-fold for AD late, gives
respectively 90% accuracy and 95% with 50 probesets for both cases.

(a) early AD patients

(b) controls

Fig. 4. Networks of the pathway GO:0019787 for AD early development patients (a) compared with healthy subjects (b). Node diameter is proportional to
the degree, and edge width is proportional to connection strength (estimated correlation).

We apply in the AD case the same network analysis strategy as in the PD experiment inferring for both cases and controls 51 selected
pathways for early stage AD and 34 for late stage AD. The full list of reconstructed pathways is reported in Table 9. In Table 3 we summarize
the main findings discussed hereafter.
Similarly to the PD analysis, we attempt a comparative analysis of the outcome for early and late stage AD having characterized the
functional alteration of pathways for the two AD stages and comment the most meaningful results from the biological viewpoint.
Four common pathways were identified: GO:0019226 i.e. transmission of nerve impulse, GO:0008015 i.e. blood circulation, GO:0000267
i.e. cell fraction and GO:0042598 i.e. vesicular fraction.
The majority of pathways characterizing early stages of AD are related to the nervous system, and the blood. Among the nervous
system related pathways the most damaged are: GO:0007399 i.e. nervous system development, GO:0007417 i.e. central nervous system
development, GO:0042391 i.e. regulation of membrane potential, GO:0042552 i.e. myelination, GO:0050877 i.e. neurological system
process, GO:0001508 i.e. regulation of action potential and GO:0019226 i.e. transmission of nerve impulse.
The majority of the pathways characterizing late stage AD are related to the cell, to the nervous system and to the response of the organism
to various stimuli, see Table 3 and 9. Among the pathways centered on the cell, mentioned in descending order based on the numerosity of
the genes, there are: GO:0008283 i.e. cell proliferation, GO:0008283 i.e. negative regulation of cell proliferation, GO:0008284 i.e. positive
regulation of cell proliferation, GO:0042127 i.e. regulation of cell proliferation, GO:0030334 i.e. regulation of cell migration. The pathways
related to the nervous system are: GO:0007268 i.e. synaptic transmission, GO:0007610 i.e. behavior, GO:0050890 i.e. cognition. Other
relevant nodes are those related to the transcription regulation (GO:0016564, GO:0045892), the visual perception (GO:0007601), and the
heme and lipid binding (i.e. GO:0020037, GO:0008289).
The genes characterizing the early stage AD are reported in Table 3 and 10. UBE2D3 is an ubiquitin, targeting abnormal or short-lived
proteins for degradation. It is a member of the E2 ubiquitin-conjugating enzyme family. This enzyme functions in the ubiquitination of the
tumor-suppressor protein p53. It is also involved in several signaling pathways (BMP, TGF-Œ≤, TNF-Œ±/NF-kB and in the immune system),
in the protein processing in the endoplasmatic reticulum. PTGDS is an enzyme that catalyzes the conversion of prostaglandin H2 (PGH2) to
postaglandin D2 (PGD2). It functions as a neuromodulator as well as a trophic factor in the central nervous system and it is also involved
in smooth muscle contraction/relaxation and is a potent inhibitor of platelet aggregation. This gene is preferentially expressed in brain.
Quantifying the protein complex of PGD2 and TTR in CSF may be useful in the diagnosis of AD, possibly in the early stages of the disease
(Lovell et al. (2008)). EGFR is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor
for members of the epidermal growth factor family that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor
dimerization and tyrosine autophosphorylation and leads to cell proliferation. This gene is involved in several pathways related to signaling,
some type of cancer, to the cell proliferation, migration and adhesion and to the axon guidance. It is expressed in pediatric brain tumors
(Patereli et al. (2010)). NTRK2 is member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound
receptor that upon neurotrophin binding phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to
cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. SNPs in this gene is associated with AD
(Cozza et al. (2008)).
The genes associated to late stage AD are listed in Table 3 and 11. Even if SNCA is a known hallmark for PD, it also known to be
expressed in late-onset familial AD (Tsuang et al. (2006)). Other relevant genes are: SPEN, EIF2AK1, CAT, HBD, ATXN1, XK. The

7

Barla et al

Table 3. AD: most important pathways ranked by normalized Ipsen-Mikhailov distance ÀÜ. The Entrez gene symbol ID is also provided for the selected
probesets g1 , ..., gk in the corresponding pathway. In bold, common pathways between early and late stage AD.

AD early

AD late

Pathway Code

ÀÜ

GO:0042598
GO:0019787
GO:0007417
GO:0001508
GO:0051246
GO:0016874
GO:0004842
GO:0005768
GO:0016567
GO:0050877
GO:0042552
GO:0008015
GO:0042391
GO:0007399
GO:0046982
GO:0006633
GO:0019226
GO:0000267

0.21
0.16
0.10
0.14
0.15
0.12
0.11
0.08
0.07
0.06
0.05
0.04
0.04
0.04
0.03
0.02
0.00
0.00

GO:0040012
GO:0042598
GO:0019226
GO:0030334
GO:0045892
GO:0042493
GO:0042127
GO:0008283
GO:0005215
GO:0008217
GO:0007601
GO:0007268
GO:0007610
GO:0008289
GO:0008015
GO:0016564
GO:0008284
GO:0008285
GO:0020037
GO:0000267
GO:0050890

0.36
0.23
0.12
0.10
0.09
0.06
0.05
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.00
0.00

Gene Symbol

UBE2D3
MPB
UBE2D3
UBE2D3
UBE2D3
EGFR
UBE2D3

NTRK2
EGFR
PTGDS

SNCA

SPEN
SNCA
CAT
XK
HBD

SPEN, ATXN1
EIF2AK1
EIF2AK1, CAT, HBD

first gene a hormone inducible transcriptional repressor. Repression of transcription by this gene product can occur through interactions
with other repressors by the recruitment of proteins involved in histone deacetylation or through sequestration of transcriptional activators.
SPEN is involved in the Notch signaling pathway that is important for cell-dell communication since it involves gene regulation mechanisms
that control multiple cell differentiation processes (i.e. neuronal function and development, stabilization of arterial endothelial fate and
angiogenesis, cardiac valve homeostasis) during embryonic and adult life. EIF2AK1 acts at the level of translation initiation to downregulate
protein synthesis in response to stress, therefore it seems to have a protective role diminishing the overproduction of proteins such as
SNCA or beta amyloid. CAT encodes for catalase a key antioxidant enzyme in the bodies defense against oxidative stress, therefore it act
against the oxidative stress present in the brain of AD patients. This gene together with EIF2AK1 seems to fight against the disease. HBD
like, HBB commented in subsection 4.2, could display the same role (Atamna and Boyle (2006)). ATXN1 i s involved in the autosomal
dominant cerebellar ataxias (ADCA), an heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of

8

Machine Learning Pipeline for Discriminant Pathways Identification

the cerebellum brain stem and spinal cord. Therefore, because of specific characteristics of these diseases (like the affected brain areas and the
characteristics of the movement disorders), it might as well play a role in AD. Finally, mutations of XK have been associated with McLeod
syndrome an X-linked recessive disorder characterized by abnormalities in the neuromuscular and hematopoietic systems.

5

CONCLUSION

The theory of complex networks has recently proven to be a helpful tool for a systematic and structural knowledge of the cell mechanisms.
Here we propose to enhance its capabilities by coupling it with a machine learning driven approach aimed at moving from a global to a
local interaction scales, that is, focussing on pathways which are most likely to change, for instance within particular pathological stages.
Such strategy is also better tailored to deal with situations where small sample size may affect the reliability of the network inference on a
global scale. The method, demonstrated on three disease datasets of environmental pollution, PD and AD, was able to detect biologically
meaningful differential pathways.

9

Barla et al

6

APPENDIX

6.1

Experimental setup for the examples

The presented analysis pipeline is independent from the single algorithms chosen for each step of the workflow. Here we give some details
about the methods used for the experiments described in Section 4.
6.1.1 Spectral Regression Discriminant Analysis (SRDA). SRDA belongs to the Discriminant Analysis algorithms family (Cai et al.
(2008)). Its peculiarity is to exploit the regression framework for improving the computational efficiency. Spectral graph analysis is used for
solving only a set of regularized least squares problems avoiding the eigenvector computation. A score is assigned to each feature and can be
interpreted as a feature weight, allowing directly feature ranking and selection. The regularization value Œ± is the only parameter needed to be
tuned. The method is implemented in Python and it is available within the mlpy library 1 .
6.1.2 The `1 `2 feature selection framework (`1 `2F S ). `1 `2F S with double optimization is a feature selection method that can be tuned
to give a minimal set of discriminative genes or larger sets including correlated genes (Zou and Hastie (2005); De Mol et al. (2009)). The
objective function is a linear model f (x) = Œ≤x, whose sign gives the classification rule that can be used to associate a new sample to one of
the two classes. The sparse weight vector Œ≤ is found by minimizing the `1 `2 functional: ||Y ‚àíŒ≤X||22 +œÑ ||Œ≤||1 +¬µ||Œ≤||22 where the least square
error is penalized with the `1 and `2 norm of the coefficient vector Œ≤. The training for selection and classification requires a careful choice
of the regularization parameters for both `1 `2 and RLS. Indeed, model selection and statistical significance assessment is performed within
two nested K-cross validation loops as in Fardin et al. (2009). The framework is implemented in Python and uses the L1L2Py library2 .
6.1.3 Functional Characterization. The Gene Set Enrichment Analysis (GSEA) was performed by using WebGestalt, an online toolkit3 .
This web-service takes as input a list of relevant genes/probesets and performs a GSEA analysis (Subramanian et al. (2005)) in Kyoto
Encyclopedia of Genes and Genomes (KEGG, Kanehisa and Goto (2000)) and Gene Ontology (GO, Ashburner et al. (2000)), identifying the
most relevant pathways and ontologies in the signatures. Both for KEGG and GO we selected the WebGestalt human genome as reference
set, 0.05 as level of significance, 3 as the minimum number of genes and the default Hypergeometric test as statistical method.
6.1.4 Weighted Gene Co-Expression Networks (WGCN). WGCN networks are based on the idea of using (a function of) the absolute
correlation between the expression of a couple of genes across the samples to define a link between them. Soft thresholding techniques are
then employed to obtain a binary adjacency matrix, where a suitable biologically motivated criterion (such as the scale-free topology, or some
other prior knowledge) can be adopted (Zhang and Horvath (2005); Zhao et al. (2010)). Due to the very small sample size, scale-freeness
can not be considered as a reliable criterion for threshold selection so we adopted a different heuristics: for both networks in the two classes
the selected threshold is the one maximising the average Ipsen-Mikhailov distance on the selected pathways.
6.1.5 Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE). ARACNE is a recent method for inferring
networks from the transcription level (Margolin et al. (2006)) to the metabolic level (Nemenman et al. (2007)). Beside it was originally
designed for handling the complexity of regulatory networks in mammalian cells, it is able to address a wider range of network deconvolution
problems. This information-theoretic algorithm removes the vast majority of indirect candidate interactions inferred by co-expression
methods by using the data processing inequality property (Cover and Thomas (1991)). In this work we use the MiNET (Mutual Information
NETworks) Bioconductor package keeping the default value for the data processing inequality tolerance parameter (Meyer et al. (2008)).
The adopted threshold criterion is the same as the one applied for WGCN.
6.1.6 Ipsen-Mikhailov distance . Although already fruitfully used even in a biological context (Sharan and Ideker (2006)), the problem
of quantitatively comparing network (e.g. using a metric instead of evaluating network properties) is a widely open issue affecting many
scientific disciplines. As discussed in (Jurman et al. (2011)), many classical distances (such as those of the edit family) have a relevant
drawback in being local, that is focussing only on the portions of the network interested by the differences in the presence/absence of matching
links. More recently, other metrics can overcome this problem so to consider the global structure of the compared topologies; among such
distances, the spectral ones - based on the list of eigenvalues of the laplacian matrix of the underlying graph - are quite interesting, and, in
particular, the Ipsen-Mikhailov (Ipsen and Mikhailov (2002)) distance has been proven to be the most robust in a wide range of situations.
The definition of the  metric follows the dynamical interpretation of a N -nodes network as a N -atoms molecules connected by identical
elastic strings, where the pattern of connections is defined by the adjacency matrix of the corresponding network (Ipsen and Mikhailov
(2002)). The vibrational frequencies œâi of the dynamical system are given by the eigenvalues of the Laplacian matrix of the network: Œªi =
N
‚àí1
X
Œ≥
‚àíœâi2 , with Œª0 = œâ0 = 0. The spectral density for a graph as the sum of Lorentz distributions is defined as œÅ(œâ) = K
,
(œâ
‚àí
œâ
k )2 + Œ≥2
i=1
R‚àû
where Œ≥ is the common width4 and K is the normalization constant solution of 0 œÅ(œâ)dœâ = 1. Then the spectral distance  between two
qR
‚àû
graphs G and H with densities œÅG (œâ) and œÅH (œâ) can then be defined as
[œÅG (œâ) ‚àí œÅH (œâ)]2 dœâ . To get a meaningful comparison
0
1
2
3
4

http://mlpy.fbk.eu/
http://slipguru.disi.unige.it/Research/L1L2Py
http://bioinfo.vanderbilt.edu/webgestalt/ (Zhang et al. (2005b))
Œ≥ specifies the half-width at half-maximum (HWHM), equal to half the interquartile range.

10

Machine Learning Pipeline for Discriminant Pathways Identification

(G, H)
, where En ,
(Fn , En )
Fn indicate respectively the empty and the fully connected network on n nodes: they are the two most -distant networks for each n. The
common width Œ≥ is set to 0.08 as in the original reference: being a multiplicative factor, it has no impact on comparing different values of
the Ipsen-Mikhailov distance. The network analysis phase is implemented in R through the igraph package.
of the value of  on pairs of networks with different number of nodes, we define the normalized version ÀÜ(G, H) =

6.2

Experiments

6.2.1 Air Pollution Experiment Table 4 lists the 11 enriched pathways identified during the analysis of the air pollution dataset and the
total number of the genes belonging to each pathway. The list is ranked by the normalized Ipsen-Mikhailov distance ÀÜ (see Section 6.1.6):
the top elements of the list are the most disrupted pathways between the two conditions. The pathways listed in Table 1 are a subset of those
reported in Table 4.
Most of these pathways concern the developmental processes: this GO class contains ontologies especially related to the development of
skeletal and nervous systems (GO:0001501 and GO:0007399) that undergo a rapid and constant growth in children. Other enriched terms are
related to the capacity of an organism to defend itself (i.e response to wounding, GO:0009611 and inflammatory response, GO:0006954), to
the regulation of the cell death (i.e. negative regulation of apoptosis, GO:0043066), the multicellular organismal process, GO:0032501, the
glycerlolipid metabolic process, GO:0046486, the response to external stimuli (i.e. inflammatory response, response to wounding) and to the
locomotion (i.e. GO:0040011, GO:0007626).
Table 4. Air Pollution Experiment: pathways corresponding to mostly discriminant genes g1 , ..., gk ranked by the normalized Ipsen-Mikhailov distance ÀÜ.
The number of genes belonging to the pathway is also provided.

Pathway

ÀÜ

# Genes

GO:0043066
GO:0001501
GO:0009611
GO:0007399
GO:0016787
GO:0005516
GO:0007275
GO:0006954
GO:0005615
GO:0007626
GO:0006066

0.257
0.149
0.123
0.093
0.078
0.076
0.076
0.048
0.038
0.000
0.000

21
89
16
252
718
116
453
180
417
5
8

Table 5 provides the subset of Agilent probesets (together with their corresponding Gene Symbol and GO pathway) belonging to the
signature g1 , ..., gk and having a non zero value of the differential node degree ‚àÜd. Since the ‚àÜd score is computed as the difference
between the weighted degree in the two classes, the top elements in Table 5 are those whose number of interactions varies most between the
two conditions.

11

Barla et al

Table 5. Air Pollution Experiment: list of Agilent probesets in the signature with their corresponding Entrez Gene Symbol ID and GO pathway. The list is
ranked according to the decreasing absolute value of the differential node degree ‚àÜd.

Agilent ID
4701
12235
8944
3697
4701
12537
13835
11673
16424
13094
8944
14787
15797
15797
11302
15797

12

Gene Symbol

Pathway

‚àÜd

NRGN
DUSP15
CLC
ITGB5
NRGN
PROK2
OLIG1
HOXB8
FKHL18
DHX32
CLC
MATN3
CXCL1
CXCL1
MYH1
CXCL1

GO:0007399
GO:0016787
GO:0016787
GO:0007275
GO:0005516
GO:0006954
GO:0007275
GO:0007275
GO:0007275
GO:0016787
GO:0007275
GO:0001501
GO:0006954
GO:0005615
GO:0005516
GO:0007399

-2.477
-1.586
-1.453
-1.390
-1.357
1.069
0.834
-0.750
-0.685
-0.575
0.561
0.495
0.467
0.338
-0.194
0.131

Machine Learning Pipeline for Discriminant Pathways Identification

6.2.2 Parkinson‚Äôs Disease Experiment Table 6 reports the list of the pathways selected by the presented approach both for the early and
late PD case, ranked by the normalized distance ÀÜ. Some of these pathways are also reported in Table 2.

Table 6. PD Experiment: selected pathways for early (left) and late (right) stage corresponding to mostly discriminant genes g1 , ..., gk ranked by the
normalized Ipsen-Mikhailov distance ÀÜ. The number of genes belonging to the pathway is also provided. In bold, the common pathways.

Pathway

PD early
ÀÜ

GO:0012501
GO:0005764
GO:0019901
GO:0005506
GO:0008219
GO:0016323
GO:0006952
GO:0046983
GO:0045087
GO:0046914
GO:0016265
GO:0042802
GO:0042803
GO:0050896
GO:0006955
GO:0006915
GO:0042981
GO:0030218
GO:0006950
GO:0020037
GO:0005938
GO:0005856
GO:0016567
GO:0003779
GO:0042592
GO:0051607
GO:0016564
GO:0005200
GO:0030097
GO:0009615
GO:0008092
GO:0030099
GO:0019900
GO:0034101
GO:0051707

0.49
0.39
0.38
0.38
0.38
0.37
0.37
0.36
0.36
0.35
0.33
0.33
0.32
0.31
0.31
0.31
0.30
0.29
0.28
0.26
0.26
0.24
0.23
0.23
0.22
0.21
0.18
0.16
0.15
0.14
0.12
0.07
0.04
0.00
0.00

PD late
ÀÜ

# Genes

Pathway

4
257
116
434
110
111
160
153
112
51
6
473
411
213
778
687
206
33
253
176
50
816
103
431
9
26
229
127
76
111
77
19
32
8
5

GO:0019226
GO:0010033
GO:0007611
GO:0030234
GO:0042493
GO:0032403
GO:0019717
GO:0009725
GO:0030424
GO:0005096
GO:0007267
GO:0050790
GO:0019001
GO:0017111
GO:0007585
GO:0005516
GO:0005626
GO:0045202
GO:0007610
GO:0005624
GO:0043087
GO:0003779
GO:0008047
GO:0042995
GO:0006928
GO:0003924
GO:0007568
GO:0043234
GO:0007268
GO:0030030
GO:0005525
GO:0006412
GO:0043005
GO:0006836
GO:0043025
GO:0042221
GO:0009266
GO:0014070
GO:0046578
GO:0050804
GO:0017076

0.31
0.20
0.16
0.15
0.15
0.12
0.12
0.11
0.10
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.08
0.08
0.08
0.08
0.08
0.07
0.07
0.07
0.07
0.06
0.06
0.06
0.05
0.05
0.05
0.05
0.05
0.04
0.00
0.00
0.00
0.00
0.00
0.00

# Genes
20
30
34
20
109
14
79
27
93
252
264
15
34
157
47
215
41
278
40
616
22
423
60
231
166
294
35
233
201
27
450
466
51
42
82
16
6
13
8
11
7

The only common pathway between early and late stage PD is actin binding (GO:0003779), as commented in Section 4.2. The specific
ones for the early stage PD concern the immune system (i.e. GO:0045087, GO:0006955), the response to stimulus (i.e. stress or other
organism like virus, GO:0006950, GO:0009615), the regulation of metabolic processes, the biological quality and cell death. The specific

13

Barla et al

pathways for late stage are related to the nervous system (e.g. neurotransmitter transport, transmission of nerve impulse, learning or memory,
GO:0006836, GO:0019226) and to response to stimuli (e.g. behavior, temperature, organic substances, drugs or endogenous stimuli).
Figure 5 visualizes the enriched pathways in the Molecular Function and Biological Process domains. Despite only one pathway was found
as common between early and late AD, it is easy to note that the majority of selected pathways belong to common GO classes.

(a) MF

(b) BP

Fig. 5. GO subgraphs for Parkinson‚Äôs early and late stage (Molecular Function and Biological Processes domains). Selected nodes are represented in light
gray, gray and dark gray for late, early and common nodes.

Tables 7 and 8 list respectively the subset of elements of the early PD signature and late PD signature having non zero differential node
degree ‚àÜd. We recall here that the top elements in the two tables are those whose number of interactions varies most between the two
case/control conditions.
In Table 7, we note that the most disrupted genes for early PD (IFI44L, HSPB1, MAFF, DEFA1/DEFA3, OXR1) belong to pathways
related to response to stress and to virus. Moreover, several genes (HLA-DQB1, HBB, HBA1/HBA2, DEFA1/DEFA3) are related to the
following pathways: heme binding, iron ion binding and immune response.
In Table 8 the majority of disrupted genes for late PD (RGS4, CDC42, RABGAPIL) occur in pathways that are related to GTP, a purine
nucleotide that can function either as source of energy for protein synthesis and in the signal transduction particularly with G-proteins. Other
genes in the list (MYH10, RGS4, PHACTR1, SYT1, VCL) are related to the acting and calmodulin binding, to the synaptic transmission,
the neurotransmitter transport, the cell-cell signaling, the translation and the cellular component movement. The majority of the disrupted
pathways are located in several components of the neurons.

14

Machine Learning Pipeline for Discriminant Pathways Identification

Table 7. PD Experiment (early): list of Affymetrix probesets in the early stage signature with their corresponding Entrez Gene Symbol ID and GO pathway.
The list is ranked according to the decreasing absolute value of the differential node degree ‚àÜd.

Affy Probeset ID
200931 s at
200931 s at
213067 at
202887 s at
201841 s at
204439 at
201841 s at
209480 at
209116 x at
203998 s at
36711 at
209116 x at
36711 at
214414 x at
205033 s at
217232 x at
205033 s at
213067 at
214414 x at
201841 s at
217232 x at
218197 s at
205033 s at

Gene Symbol

Pathway

‚àÜd

VCL
VCL
MYH10
DDIT4
HSPB1
IFI44L
HSPB1
HLA-DQB1
HBB
SYT1
MAFF
HBB
MAFF
HBA1/HBA2
DEFA1/DEFA3
HBB
DEFA1/DEFA3
MYH10
HBA1/HBA2
HSPB1
HBB
OXR1
DEFA1/DEFA3

GO:0005856
GO:0003779
GO:0003779
GO:0006915
GO:0042802
GO:0006955
GO:0005856
GO:0006955
GO:0005506
GO:0042802
GO:0006950
GO:0020037
GO:0046983
GO:0020037
GO:0009615
GO:0005506
GO:0006955
GO:0005938
GO:0005506
GO:0006950
GO:0020037
GO:0006950
GO:0006952

-2.124
-2.107
1.879
-1.872
-1.691
-1.585
-1.532
-1.340
-1.008
0.862
-0.807
-0.599
0.567
-0.376
-0.360
-0.239
-0.228
0.183
-0.182
-0.154
-0.088
-0.059
0.027

15

Barla et al

Table 8. PD Experiment (late): list of Affymetrix probesets in the late stage signature with their corresponding Entrez Gene Symbol and GO pathway. The
list is ranked according to the decreasing absolute value of the differential node degree ‚àÜd.

Affy Probeset ID
213638
213067
213067
204337
213067
213067
214230
213638
213067
205857
206552
206552
205110
203998
208319
201909
200931
204337
205105
205857
201841
214230
214230
203998
203998
200931
200931
206836
215342
211727
203998

16

at
at
at
at
at
at
at
at
at
at
s at
s at
s at
s at
s at
at
s at
at
at
at
s at
at
at
s at
s at
s at
s at
at
s at
s at
s at

Entrez Gene Symbol

Pathway

‚àÜd

PHACTR1
MYH10
MYH10
RGS4
MYH10
MYH10
CDC42
PHACTR1
MYH10
SLC18A2
TAC1
TAC1
FGF13
SYT1
RBM3
RPS4Y
VCL
RGS4
MAN2A1
SLC18A2
HSPB1
CDC42
CDC42
SYT1
SYT1
VCL
VCL
SLC6A3
RABGAP1L
COX11
SYT1

GO:0045202
GO:0003779
GO:0005516
GO:0005096
GO:0043025
GO:0043005
GO:0003924
GO:0003779
GO:0030424
GO:0006836
GO:0007268
GO:0007267
GO:0007267
GO:0005516
GO:0006412
GO:0006412
GO:0043234
GO:0005516
GO:0007585
GO:0005624
GO:0006928
GO:0042995
GO:0005525
GO:0043005
GO:0045202
GO:0003779
GO:0006928
GO:0006836
GO:0005096
GO:0007585
GO:0007268

-3.255
-3.252
-2.597
-2.194
-2.107
-1.696
1.677
-1.587
-1.170
-1.094
-0.834
0.809
-0.804
-0.787
-0.759
-0.688
-0.655
-0.602
-0.502
-0.428
0.424
-0.379
0.370
-0.357
-0.339
-0.311
-0.308
-0.238
-0.211
0.188
-0.159

Machine Learning Pipeline for Discriminant Pathways Identification

6.2.3 Alzheimer‚Äôs Disease Experiment Table 9 reports the most discriminant pathways for the two AD stages as selected by the
presented pipeline, ranked by decreasing normalized ÀÜ distance. Table 3 summarizes the main results here detailed in Table 9, 10 and
11. The common pathways are: GO:0019226 i.e. transmission of nerve impulse, GO:0008015 i.e. blood circulation, GO:0000267 i.e. cell
fraction and GO:0042598 i.e. vesicular fraction. The relevance of blood circulatory system in AD has already been highlighted in Brown
and Thore (2011) and references therein.
Figure 6 visualizes the enriched pathways in the Molecular Function and Biological Process domains. Despite only 4 pathways were found
as common between early and late AD, it is easy to note that the majority of selected pathways belong to common GO classes.

(a) MF

(b) BP

Fig. 6. GO subgraphs for Alzheimer‚Äôs early and late stage (Molecular Function and Biological Processes domains). Selected nodes are represented in light
gray, gray and dark gray for late, early and common nodes.

Tables 10 and 11 provide details of the network analysis results on early and late stage AD, respectively. The elements of the two signatures
having non zero ‚àÜd are listed for decreasing absolute value of the differential node degree score, thus giving top positions to genes that change
most the interaction network between the case/control condition.
Table 10 reports the most disrupted probesets within the early stage AD, ranked according to the differential node degree ‚àÜd. We note that
the most disrupted gene is HBB, within regulation of blood vessel size and regulation of blood vessels.
Table 11 reports the most disrupted genes within the late stage AD, ranked according to the differential node degree ‚àÜd. The majority
of such genes (SPEN, SNCA, EIF2AK1, ELF1, CAT, ATXN1, HBD) belong to regulation of locomotion, transcription repressor activity,
response to drug and heme binding.

17

Barla et al

Table 9. AD Experiment: selected pathways for early (left) and late (right) stage corresponding to mostly discriminant genes g1 , ..., gk ranked by the
normalized Ipsen-Mikhailov distance ÀÜ. The number of genes belonging to the pathway is also provided. In bold, the common pathways.

AD early
Pathway
ÀÜ
GO:0048514
GO:0042598
GO:0016881
GO:0019787
GO:0019725
GO:0051246
GO:0001508
GO:0006631
GO:0030234
GO:0016874
GO:0004842
GO:0007417
GO:0012505
GO:0050880
GO:0048471
GO:0005792
GO:0005768
GO:0004857
GO:0031982
GO:0016567
GO:0008217
GO:0001666
GO:0030141
GO:0050877
GO:0042552
GO:0001568
GO:0048511
GO:0016023
GO:0007399
GO:0008015
GO:0042391
GO:0031410
GO:0046982
GO:0006633
GO:0045121
GO:0004866
GO:0008366
GO:0019228
GO:0006873
GO:0042592
GO:0001974
GO:0019226
GO:0001944
GO:0048771
GO:0048856
GO:0019838
GO:0017076
GO:0030414
GO:0001882
GO:0000267
GO:0031090

18

0.22
0.21
0.19
0.16
0.16
0.15
0.14
0.14
0.13
0.12
0.11
0.10
0.10
0.09
0.08
0.08
0.08
0.08
0.07
0.07
0.07
0.07
0.06
0.06
0.05
0.05
0.04
0.04
0.04
0.04
0.04
0.03
0.03
0.02
0.02
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

AD late
ÀÜ

# Genes

Pathway

22
16
109
116
14
121
31
171
29
735
368
199
216
26
263
409
490
57
34
206
105
225
69
31
36
79
49
108
806
103
67
482
364
109
136
194
22
19
10
25
28
27
4
12
20
85
11
42
8
4
6

GO:0040012
GO:0042598
GO:0019226
GO:0030334
GO:0045892
GO:0009968
GO:0042493
GO:0050877
GO:0042127
GO:0009725
GO:0042277
GO:0015630
GO:0008283
GO:0005819
GO:0008217
GO:0005626
GO:0000165
GO:0005215
GO:0007268
GO:0007601
GO:0008289
GO:0007610
GO:0008284
GO:0001503
GO:0007243
GO:0008285
GO:0008015
GO:0016564
GO:0020037
GO:0051270
GO:0010033
GO:0050890
GO:0050953
GO:0000267

0.36
0.23
0.12
0.10
0.09
0.06
0.06
0.06
0.05
0.05
0.05
0.05
0.04
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.00
0.00
0.00
0.00
0.00

# Genes
9
16
27
93
218
107
160
31
140
47
63
99
785
142
106
68
94
685
377
402
285
84
507
171
220
578
103
380
265
9
44
31
24
5

Machine Learning Pipeline for Discriminant Pathways Identification

Table 10. AD Experiment (early): list of Affymetrix probesets in the early stage signature with their corresponding Entrez Gene Symbol and GO pathway.
The list is ranked according to the decreasing absolute value of the differential node degree ‚àÜd.

Affy Probeset ID

Gene Symbol

209116
209116
211748
240383
240383
201061
240383
201983
221795
212226
201983
211696
209072
211696
212187
201185
240383
209072
240383

HBB
HBB
PTGDS
UBE2D3
UBE2D3
STOM
UBE2D3
EGFR
NTRK2
PPAP2B
EGFR
HBB
MBP
HBB
PTGDS
HTRA1
UBE2D3
MBP
UBE2D3

x at
x at
x at
at
at
s at
at
s at
at
s at
s at
x at
at
x at
x at
at
at
at
at

Pathway

‚àÜd

GO:0050880
GO:0008217
GO:0006633
GO:0016874
GO:0019787
GO:0045121
GO:0051246
GO:0046982
GO:0007399
GO:0001568
GO:0005768
GO:0050880
GO:0008366
GO:0008217
GO:0006633
GO:0019838
GO:0004842
GO:0007417
GO:0016567

1.670
1.445
1.273
-1.165
-0.703
-0.662
-0.613
-0.476
-0.262
0.259
-0.256
-0.224
0.166
-0.149
-0.139
0.124
0.120
0.113
-0.047

Table 11. AD Experiment (late): list of Affymetrix probesets in the late stage signature with their corresponding Entrez Gene Symbol and GO pathway. The
list is ranked according to the decreasing absolute value of the differential node degree ‚àÜd.

Affy Probeset ID

Gene Symbol

201996
211546
211546
201996
217736
201005
210943
204466
207827
206698
209184
212420
207827
205592
211922
211922
203231
217736
204466
206834
206834

SPEN
SNCA
SNCA
SPEN
EIF2AK1
CD9
LYST
SNCA
SNCA
XK
IRS2
ELF1
SNCA
SLCA4A1
CAT
CAT
ATXN1
EIF2AK1
SNCA
HBD
HBD

s at
x at
x at
s at
s at
at
s at
s at
x at
at
s at
at
x at
at
s at
s at
s at
s at
s at
at
at

Pathway

‚àÜd

GO:0016564
GO:0040012
GO:0042493
GO:0045892
GO:0020037
GO:0008285
GO:0015630
GO:0042493
GO:0040012
GO:0005215
GO:0008283
GO:0016564
GO:0042493
GO:0005215
GO:0008283
GO:0020037
GO:0016564
GO:0008285
GO:0040012
GO:0008217
GO:0020037

1.590
1.410
1.310
1.246
-1.066
0.725
0.706
0.461
0.434
0.433
0.208
-0.203
0.201
0.180
0.173
-0.094
-0.073
-0.072
0.048
0.045
0.019

19

Barla et al

REFERENCES
Andrianov, G. N., Nozdrachev, A. D., and Ryzhova, I. V. (2007). The role of defensins in the excitability of the peripheral vestibular system in the frog: evidence for the presence of
communication between the immune and nervous systems. Hear Res, 230(1-2), 1‚Äì8.
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., K., D., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis,
A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000). Gene ontology: tool for the unification of biology. the gene ontology
consortium. Nature Genetics, 25(1), 25‚Äì9.
Atamna, H. and Boyle, K. (2006). Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer‚Äôs disease. PNAS, 103(9), 3381‚Äì6.
Barabasi, A. L., Gulbahce, N., and Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nature Review Genetics, 12, 56‚Äì68.
Baralla, A., Mentzen, W., and de la Fuente, A. (2009). Inferring Gene Networks: Dream or Nightmare? Ann. N.Y. Acad. Sci., 1158, 246‚Äì256.
Boccaletti, S., Latora, V., Moreno, Y., Chavez, M., and Hwang, D.-U. (2006). Complex networks: Structure and dynamics. Physics Reports, 424(4‚Äì5), 175‚Äì308.
Brown, W. R. and Thore, C. R. (2011). Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol, 37(1), 56‚Äì74.
Buchanan, M., Caldarelli, G., De Los Rios, P., Rao, F., and Vendruscolo, M., editors (2010). Networks in Cell Biology. Cambridge University Press.
Cai, D., He, X., and Han, J. (2008). Srda: An efficient algorithm for large-scale discriminant analysis. IEEE Transactions on Knowledge and Data Engineering, 20, 1‚Äì12.
Cover, T. and Thomas, J. (1991). Elements of Information Theory. Wiley.
Cozza, A., Melissari, E., Iacopetti, P., Mariotti, V., Tedde, A., Nacmias, B., Conte, A., Sorbi, S., and Pellegrini, S. (2008). Snps in neurotrophin system genes and alzheimer‚Äôs disease
in an italian population. J Alzheimers Dis, 15(1), 61‚Äì70.
De Mol, C., Mosci, S., Traskine, M., and Verri, A. (2009). A regularized method for selecting nested groups of relevant genes from microarray data. Journal of Computational
Biology, 16, 1‚Äì15.
De Smet, R. and Marchal, K. (2010). Advantages and limitations of current network inference methods. Nature Review Microbiology, 8, 717‚Äì729.
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., and Varesio, L. (2009). The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a
set of heterogeneous neuroblastoma cell lines. BMC Genomics.
Friedman, M. J., Li, S., and Li, X.-J. (2009). Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection. J Biol Chem, 284(41), 27944‚Äì51.
Grupe, A., Li, Y., Rowland, C., Nowotny, P., Hinrichs, A. L., Smemo, S., Kauwe, J. S. K., Maxwell, T. J., Cherny, S., Doil, L., Tacey, K., van Luchene, R., Myers, A., VrieÃÄze,
F. W.-D., Kaleem, M., Hollingworth, P., Jehu, L., Foy, C., Archer, N., Hamilton, G., Holmans, P., Morris, C. M., Catanese, J., Sninsky, J., White, T. J., Powell, J., Hardy, J.,
O‚ÄôDonovan, M., Lovestone, S., Jones, L., Morris, J. C., Thal, L., Owen, M., Williams, J., and Goate, A. (2006). A scan of chromosome 10 identifies a novel locus showing strong
association with late-onset alzheimer disease. Am J Hum Genet, 78(1), 78‚Äì88.
He, F., Balling, R., and Zeng, A.-P. (2009). Reverse engineering and verification of gene networks: Principles, assumptions, and limitations of present methods and future
perspectives. J. Biotechnol., 144(3), 190‚Äì203.
Ipsen, M. and Mikhailov, A. (2002). Evolutionary reconstruction of networks. Phys. Rev. E, 66(4), 046109.
Jurman, G., Visintainer, R., and Furlanello, C. (2011). An introduction to spectral distances in networks. In Proc. WIRN 2010, pages 227‚Äì234.
Kanehisa, M. and Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res, 28(1), 27‚Äì30.
Kim, K.-Y., KovaÃÅcs, M., Kawamoto, S., Sellers, J. R., and Adelstein, R. S. (2005). Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of
nonmuscle myosins ii-b and ii-c. J Biol Chem, 280(24), 22769‚Äì75.
Kurian, M. A., Zhen, J., Cheng, S.-Y., Li, Y., Mordekar, S. R., Jardine, P., Morgan, N. V., Meyer, E., Tee, L., Pasha, S., Wassmer, E., Heales, S. J. R., Gissen, P., Reith, M. E. A., and
Maher, E. R. (2009). Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest,
119(6), 1595‚Äì603.
Liang, W., Reiman, E., Valla, J., Dunckley, T., Beach, T., Grover, A., Niedzielko, T., Schneider, L., Mastroeni, D., Caselli, R., Kukull, W., Morris, J., Hulette, C., Schmechel, D.,
Rogers, J., and Stephan, D. (2008). Alzheimer‚Äôs disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. PNAS, 105, 4441‚Äì4446.
Liang, W., Dunckley, T., Beach, T., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R., Kukull, W., Mckeel, D., Morris, J., Hulette, C., Schmechel, D., Reiman, E., Rogers, J., and
Stephan, D. (2010). Neuronal gene expression in non-demented individuals with intermediate alzheimer‚Äôs disease neuropathology. Neurobiol Aging, 31, 1‚Äì16.
Lovell, M. A., Lynn, B. C., Xiong, S., Quinn, J. F., Kaye, J., and Markesbery, W. R. (2008). An aberrant protein complex in csf as a biomarker of alzheimer disease. Neurology,
70(23), 2212‚Äì8.
Marbach, D., Prill, R., Schaffter, T., Mattiussi, C., Floreano, D., and Stolovitzky, G. (2010). Revealing strenghts and weaknesses of methods for gene network inference. PNAS,
107(14), 6286‚Äì6291.
Margolin, A., Nemenman, I., Basso, K., Wiggins, C., Stolovitzky, G., Dalla-Favera, R., and Califano, A. (2006). Aracne: an algorithm for the reconstruction of gene regulatory
networks in a mammalian cellular context. BMC Bioinform., 7(7).
Meyer, P., Lafitte, F., and Bontempi, G. (2008). minet: A R/Bioconductor Package for Inferring Large Transcriptional Networks Using Mutual Information. BMC Bioinform., 9(1),
461.
Nemenman, I., Escola, G., Hlavacek, W., Unkefer, P., Unkefer, C., and Wall, M. (2007). Reconstruction of Metabolic Networks from High-Throughput Metabolite Profiling Data.
Ann. N.Y. Acad. Sci., 1115, 102‚Äì115.
Newman, M. (2003). The Structure and Function of Complex Networks. SIAM Review, 45, 167‚Äì256.
Newman, M. (2010). Networks: An Introduction. Oxford University Press.
Patereli, A., Alexiou, G. A., Stefanaki, K., Moschovi, M., Doussis-Anagnostopoulou, I., Prodromou, N., and Karentzou, O. (2010). Expression of epidermal growth factor receptor
and her-2 in pediatric embryonal brain tumors. Pediatr Neurosurg, 46(3), 188‚Äì92.
Scherzer, C., Eklund, A., Morse, L., and al. (2007). Molecular markers of early Parkinson‚Äôs disease based on gene expression in blood. PNAS.
Sharan, R. and Ideker, T. (2006). Modeling cellular machinery through biological network comparison. Nature Biotechnology, 24(4), 427‚Äì433.
Shi, M., Bradner, J., Hancock, A. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D., Jankovic, J., Zabetian, C. P., Kim, H. M., Leverenz, J. B., Montine, T. J., Ginghina, C.,
Kang, U. J., Cain, K. C., Wang, Y., Aasly, J., Goldstein, D., and Zhang, J. (2011). Cerebrospinal fluid biomarkers for parkinson disease diagnosis and progression. Ann Neurol,
69(3), 570‚Äì80.
Strogatz, S. (2001). Exploring complex networks. Nature, 410, 268‚Äì276.
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005). Gene
set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. PNAS, 102(43), 15545‚Äì15550.
The MicroArray Quality Control Consortium, . (2010). The MAQC-II Project: A comprehensive study of common practices for the development and validation of microarray-based
predictive models. Nature biotechnology, 28(8), 827‚Äì838.
Tsuang, D. W., Riekse, R. G., Purganan, K. M., David, A. C., Montine, T. J., Schellenberg, G. D., Steinbart, E. J., Petrie, E. C., Bird, T. D., and Leverenz, J. B. (2006). Lewy body
pathology in late-onset familial alzheimer‚Äôs disease: a clinicopathological case series. J Alzheimers Dis, 9(3), 235‚Äì42.
van Leeuwen, D., van Herwijnen, M., Pedersen, M., Knudsen, L., Kirsch-Volders, M., Sram, R., Staal, Y., Bajak, E., van Delft, J., and Kleinjans, J. (2006). Genome-wide differential
gene expression in children exposed to air pollution in the czech republic. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 600(1‚Äì2), 12‚Äì22.
van Leeuwen, D., Pedersen, M., Hendriksen, P., Boorsma, A., van Herwijnen, M., Gottschalk, R., Kirsch-Volders, M., Knudsen, L., Sram, R., Bajak, E., van Delft, J., and Kleinjans,
J. (2008). Genomic analysis suggests higher susceptibility of children to air pollution. Carcinogenesis, 29(5).

20

Machine Learning Pipeline for Discriminant Pathways Identification

Zhang, B. and Horvath, S. (2005). A General Framework for Weighted Gene Co-Expression Network Analysis. Statistical Applications in Genetics and Molecular Biology, 4(1),
Article 17.
Zhang, B., Kirov, S., and Snoddy, J. (2005a). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nuc. Acid. Res., 33.
Zhang, B., Kirov, S., and Snoddy, J. (2005b). Webgestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33.
Zhang, Y., James, M., Middleton, F., and Davis, R. (2005c). Transcriptional analysis of multiple brain regions in Parkinson‚Äôs disease supports the involvement of specific protein
processing, energy metabolism and signaling pathways and suggests novel disease mechanisms. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 137B,
5‚Äì16.
Zhao, W., Langfelder, P., Fuller, T., Dong, J., Li, A., and Horvath, S. (2010). Weighted gene coexpression network analysis: state of the art. Journal of Biopharmaceutical Statistics,
20(2), 281‚Äì300.
Zou, H. and Hastie, T. (2005). Regularization and variable selection via the elastic net. Journal of the Royal Statistical Society, Series B.

21

